Here we explored lipid metabolism defects in CD4 + T-cells from patients with RRMS, with a focus on examining the role of LXRβ-regulated pathways on CD4 + T-cell lipid raft composition and function. The gene discussed is NR1H2; the disease is relapsing-remitting multiple sclerosis.